Clinical trial
Imaging and Genetic Biomarkers of Parkinson Disease (PD) Onset and Progression…
NCT00273351 · Institute for Neurodegenerative Disorders, Other · Completed
Key facts
| NCT number | NCT00273351 |
|---|---|
| Title | Imaging and Genetic Biomarkers of Parkinson Disease (PD) Onset and Progression in High-risk Families |
| Official title | Assessment of Pre-symptomatic and Symptomatic Patients With Parkinson Disease to Identify and Characterize Genetic and Phenotypic Biomarkers for Disease Onset and Progression. |
| Lead sponsor | Institute for Neurodegenerative Disorders, Other |
| Collaborators | United States Department of Defense U.S. Fed Molecular NeuroImaging |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Parkinson Disease, Parkinsonian Syndrome |
| Intervention type | Drug |
| Interventions | [123I]B-CIT |
| Enrollment | 62 |
| Start date | Jan 1, 2006 |
| Primary completion | Jan 1, 2008 |
| Completion | Jan 1, 2008 |
| First posted | Jan 9, 2006 |
| Last update posted | May 9, 2014 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: